Spotlight on ARC: Advancing Clinical Research Excellence • Liver Spot • Hepatitis C Elimination...
Read More
Key Takeaways The phase 2 study of a bemnifosbuvir and ruzasvir regimen for the...
Fabian Rodas Ochoa, MD, transplant hepatologist and clinical assistant professor of medicine at UT...
This edition includes: • REZDIFFRA™ (Resmetirom): A New Hope for Patients with Advanced Fibrosis in...
Survodutide has an “acceptable safety profile” in patients with metabolic dysfunction-associated steatohepatitis with compensated and decompensated cirrhosis,...
Texas Liver Institute’s Dr. Eric Lawitz and colleagues publish clinical trial results on 2...